Ogawa T, Linz W, Stevenson M, Bruneau B G, Kuroski de Bold M L, Chen J H, Eid H, Schölkens B A, de Bold A J
University of Ottawa Heart Institute, Ottawa Civic Hospital, Ontario, Canada.
Circulation. 1996 Jun 1;93(11):2059-67. doi: 10.1161/01.cir.93.11.2059.
In hypertension with cardiac hypertrophy, the specific contributions to increased production of the cardiac natriuretic peptides (NP) atrial natriuretic factor (ANF) and brain natriuretic peptide (BNP) by load and the hypertrophic process are not known. In the present work we determine ANF and BNP synthesis and secretion in the aortic-banded rat treated with dosage schedules of the ACE inhibitor ramipril that result in the prevention or regression of both hypertension and hypertrophy (high dosage) or in the prevention or regression of hypertrophy alone with persistent hypertension (low dosage). Myosin heavy chain (MHC) isoform switch was studied as an indicator of ventricular cardiocyte hypertrophy as well as the levels of collagen III mRNA as a measure of changes in extracellular matrix.
Ramipril was administered for 6 weeks just after suprarenal aortic banding, or rats were banded for 6 weeks, after which ramipril was administered during the following 6 weeks. Banding caused an increase in blood pressure, left ventricular weight-to-body weight ratio, plasma and ventricular NP, ventricular NP mRNA, collagen III, and beta-MHC mRNA. Ramipril at 1 mg/kg normalized all these parameters while ramipril at 10 micrograms/kg normalized left ventricular weight-to-body weight ratio but not blood pressure. Plasma and ventricular NP content and mRNA levels were partially normalized by ramipril (10 micrograms/kg). Ramipril (10 micrograms/kg) prevented increased collagen III mRNA levels but did not affect beta-MHC mRNA levels.
(1) NP production and secretion in aortic-banded rats are independently related to increased blood pressure and hypertrophy. (2) A load-dependent component is more important than a load-independent component in regulating left ventricular NP production. (3) ANF production is more sensitive than BNP production to the load-independent component. (4) Low-dose ramipril treatment reverses hypertrophy and the increased collagen III expression but does not reverse the increased beta-MHC isoform expression, suggesting that these are independently regulated processes. (5) Aortic banding and ACE inhibition do not affect atrial NP production and content.
在伴有心脏肥大的高血压患者中,负荷及肥大过程对心脏利钠肽(NP)心房利钠因子(ANF)和脑利钠肽(BNP)分泌增加的具体作用尚不清楚。在本研究中,我们测定了用血管紧张素转换酶(ACE)抑制剂雷米普利不同剂量方案治疗的主动脉缩窄大鼠中ANF和BNP的合成与分泌情况,这些方案可导致高血压和肥大的预防或逆转(高剂量),或仅预防或逆转肥大而高血压持续存在(低剂量)。研究了肌球蛋白重链(MHC)异构体转换作为心室心肌细胞肥大的指标,以及III型胶原mRNA水平作为细胞外基质变化的衡量指标。
在肾上腺上方主动脉缩窄后立即给予雷米普利6周,或者大鼠先缩窄6周,然后在接下来的6周内给予雷米普利。缩窄导致血压、左心室重量与体重比值、血浆和心室NP、心室NP mRNA、III型胶原和β-MHC mRNA增加。1mg/kg的雷米普利使所有这些参数恢复正常,而10μg/kg的雷米普利使左心室重量与体重比值恢复正常,但血压未恢复正常。雷米普利(10μg/kg)使血浆和心室NP含量及mRNA水平部分恢复正常。雷米普利(10μg/kg)可预防III型胶原mRNA水平升高,但不影响β-MHC mRNA水平。
(1)主动脉缩窄大鼠中NP的产生和分泌与血压升高和肥大独立相关。(2)在调节左心室NP产生方面,负荷依赖性成分比负荷非依赖性成分更重要。(3)ANF产生对负荷非依赖性成分比BNP产生更敏感。(4)低剂量雷米普利治疗可逆转肥大和III型胶原表达增加,但不能逆转β-MHC异构体表达增加,提示这些是独立调节的过程。(5)主动脉缩窄和ACE抑制不影响心房NP的产生和含量。